Leadership of Searchlight Pharma, the innovative specialty pharma division of Apotex, following the sale of Searchlight to Apotex in 2024.Member of the Apotex global Executive Leadership Team, reporting to the CEO of Apotex.

www.searchlightpharma.com Co-Founder of Montreal-based specialty pharma focused on the acquisition and commercialization of innovative and unique specialty healthcare products and pharmaceuticals.Raised CAD ~$150M in external capital to grow Searchlight from an idea with starting revenues <$1M into the leading independent, Canadian-headquartered branded specialty pharma.External recognition of strategic success via inclusion on The Globe and Mail and Report on Business Magazine's ranking of Canada's Top Growing Companies for 6 consecutive years (2019 - 2024), culminating with a ranking at #37 in 2024 with a 3-year growth rate of 1,121%.External recognition of cultural and organizational successes via Great Place to Work Canada certification in 2023 and the inclusion of Searchlight Pharma on the Best Places to Work in Healthcare 2024 and Best Places to Work in Quebec 2023 lists.Significant M&A experience having championed and led the acquisitions of Besins Healthcare Canada (2016), Erfa Canada (2021), Miravo Healthcare (2023) and the sale of Searchlight to Apotex (2024).Commercial experience spanned creation and oversight of a sales and marketing function that grew revenues from <$1M to >$150M in under 10 years. This included the launch and re-launch of multiple brands, the design and management of commercial sales teams, the alliance management of multiple corporate partnerships, and the oversight of all commercial support functions to enable and manage such growth.

Non-executive member of the Board of Directors of Intelgenx Corp (TSX: IGX) (OTCQB: IGXT).

Chairman of the Board of Directors of Kane Biotech (TSX-V: KNE), Chair of the Audit Committee.

Non-executive member of the Board of Directors of Kane Biotech (TSX-V: KNE), Chair of the Audit Committee.

Non-executive Member of the Board of the Directors of publicly-traded Litha Healthcare Group (JHB:LHG), member of its Investment Committee and member-by-invitation of its Audit Committee

Responsible for corporate M&A, product in/out licensing and acquisitions, international business expansion and management, and product development activities.